ArticleCardiovascular toxicology2025
Caffeine Intake Attenuates the Association of Cadmium Exposure with Cardiovascular Disease: National Health and Nutrition Examination Survey (NHANES) 2003-2016.
Article in Cardiovascular toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundCadmium exposure has been linked to an increased risk of cardiovascular disease (CVD). Moderate caffeine intake may reduce the risk of CVD. Whether caffeine intake attenuates the association of cadmium exposure with CVD remains unknown.
methodsThe study used cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2016. Cadmium exposure was estimated by urinary cadmium after adjusting for urinary creatinine (UCd/Cr, μg/g). Caffeine intake was determined using the average of two 24-h dietary recalls. Logistic regression models were used to examine the association of cadmium exposure with CVD and to evaluate the multiplicative interaction between caffeine intake and cadmium exposure.
resultsA total of 7,094 adults aged 20 or older were included in the study, of whom 827 had CVD. The multivariate-adjusted odds ratio (OR) of participants in the highest quartile was 2.10 (95% confidence interval: 1.34-3.28) for CVD compared to participants in the lowest UCd/Cr quartile. The OR of ln-UCd/Cr as a continuous variable was 1.46 (95% confidence interval: 1.23-1.73). Moreover, a significant interaction between caffeine intake and cadmium exposure on CVD was observed (P for interaction = 0.004). The relatively lowest ORs of cadmium exposure with CVD were observed in participants with low or moderate caffeine intake (caffeine intake quartile 2 and quartile 3) in almost all subgroups.
conclusionsHigher cadmium exposure was associated with increased CVD risk in US adults. Low-to-moderate caffeine intake tends to attenuate this association. Further studies are needed to confirm causality and underlying mechanisms.
Indexed as
Identifiers
40650791What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.